Human Molecular Genetics Advance Access originally published online on February 12, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Molecular Genetics, 2004, Vol. 13, No. 7 703-714
DOI: 10.1093/hmg/ddh083
CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation
1Mayo Clinic, Jacksonville, FL 32224, USA, 2Loyola University School of Medicine, Department of Pharmacology, Maywood, IL 60153, USA, 3University of California, Department of Medicine, La Jolla, CA, USA, 4Weill Medical College of Cornell University, New York, NY 10021, USA, 5University of Miami School of Medicine, Miami, FL 33136, USA, 6Fukuoka University, Department of Internal Medicine, Japan, 7Institute for Cell Engineering, 8Department of Neurology, 9Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA and 10National Institutes of Health, Department of Neurogenetics, Bethseda, MD 20892, USA
Received November 17, 2003; Accepted January 30, 2004
Molecular chaperones, ubiquitin ligases and proteasome impairment have been implicated in several neurodegenerative diseases, including Alzheimer's and Parkinson's disease, which are characterized by accumulation of abnormal protein aggregates (e.g. tau and 
-synuclein respectively). Here we report that CHIP, an ubiquitin ligase that interacts directly with Hsp70/90, induces ubiquitination of the microtubule associated protein, tau. CHIP also increases tau aggregation. Consistent with this observation, diverse of tau lesions in human postmortem tissue were found to be immunopositive for CHIP. Conversely, induction of Hsp70 through treatment with either geldanamycin or heat shock factor 1 leads to a decrease in tau steady-state levels and a selective reduction in detergent insoluble tau. Furthermore, 30-month-old mice overexpressing inducible Hsp70 show a significant reduction in tau levels. Together these data demonstrate that the Hsp70/CHIP chaperone system plays an important role in the regulation of tau turnover and the selective elimination of abnormal tau species. Hsp70/CHIP may therefore play an important role in the pathogenesis of tauopathies and also represents a potential therapeutic target.
* To whom correspondence should be addressed at: Department of Neuroscience, 4500 San Pablo Road, Jacksonville, FL 32224, USA. Email: hutton.michael{at}mayo.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Wang, M. Martinez-Vicente, U. Kruger, S. Kaushik, E. Wong, E.-M. Mandelkow, A. M. Cuervo, and E. Mandelkow Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing Hum. Mol. Genet., November 1, 2009; 18(21): 4153 - 4170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. K. Jinwal, Y. Miyata, J. Koren III, J. R. Jones, J. H. Trotter, L. Chang, J. O'Leary, D. Morgan, D. C. Lee, C. L. Shults, et al. Chemical Manipulation of Hsp70 ATPase Activity Regulates Tau Stability J. Neurosci., September 30, 2009; 29(39): 12079 - 12088. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Puri, T. Suzuki, K. Yamakawa, and S. Ganesh Hyperphosphorylation and Aggregation of Tau in Laforin-deficient Mice, an Animal Model for Lafora Disease J. Biol. Chem., August 21, 2009; 284(34): 22657 - 22663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mishra, S. K. Godavarthi, M. Maheshwari, A. Goswami, and N. R. Jana The Ubiquitin Ligase E6-AP Is Induced and Recruited to Aggresomes in Response to Proteasome Inhibition and May Be Involved in the Ubiquitination of Hsp70-bound Misfolded Proteins J. Biol. Chem., April 17, 2009; 284(16): 10537 - 10545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Carrettiero, I. Hernandez, P. Neveu, T. Papagiannakopoulos, and K. S. Kosik The Cochaperone BAG2 Sweeps Paired Helical Filament- Insoluble Tau from the Microtubule J. Neurosci., February 18, 2009; 29(7): 2151 - 2161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Dickey, C. Kraft, U. Jinwal, J. Koren, A. Johnson, L. Anderson, L. Lebson, D. Lee, D. Dickson, R. de Silva, et al. Aging Analysis Reveals Slowed Tau Turnover and Enhanced Stress Response in a Mouse Model of Tauopathy Am. J. Pathol., January 1, 2009; 174(1): 228 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Mena and J. Garcia de Yebenes Glial Cells as Players in Parkinsonism: The "Good," the "Bad," and the "Mysterious" Glia Neuroscientist, December 1, 2008; 14(6): 544 - 560. [Abstract] [PDF]
|
|
|
|
|
|
S. Oddo, A. Caccamo, B. Tseng, D. Cheng, V. Vasilevko, D. H. Cribbs, and F. M. LaFerla Blocking A{beta}42 Accumulation Delays the Onset and Progression of Tau Pathology via the C Terminus of Heat Shock Protein70-Interacting Protein: A Mechanistic Link between A{beta} and Tau Pathology J. Neurosci., November 19, 2008; 28(47): 12163 - 12175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Rodriguez-Navarro, A. Gomez, I. Rodal, J. Perucho, A. Martinez, V. Furio, I. Ampuero, M. J. Casarejos, R. M. Solano, J. G. de Yebenes, et al. Parkin deletion causes cerebral and systemic amyloidosis in human mutated tau over-expressing mice Hum. Mol. Genet., October 15, 2008; 17(20): 3128 - 3143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Tetzlaff, P. Putcha, T. F. Outeiro, A. Ivanov, O. Berezovska, B. T. Hyman, and P. J. McLean CHIP Targets Toxic {alpha}-Synuclein Oligomers for Degradation J. Biol. Chem., June 27, 2008; 283(26): 17962 - 17968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-N. Min, R. A. Whaley, N. E. Sharpless, P. Lockyer, A. L. Portbury, and C. Patterson CHIP Deficiency Decreases Longevity, with Accelerated Aging Phenotypes Accompanied by Altered Protein Quality Control Mol. Cell. Biol., June 15, 2008; 28(12): 4018 - 4025. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. S. Liang, T. Dunckley, T. G. Beach, A. Grover, D. Mastroeni, K. Ramsey, R. J. Caselli, W. A. Kukull, D. McKeel, J. C. Morris, et al. Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set Physiol Genomics, April 1, 2008; 33(2): 240 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mishra, P. Dikshit, S. Purkayastha, J. Sharma, N. Nukina, and N. R. Jana E6-AP Promotes Misfolded Polyglutamine Proteins for Proteasomal Degradation and Suppresses Polyglutamine Protein Aggregation and Toxicity J. Biol. Chem., March 21, 2008; 283(12): 7648 - 7656. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Dickey, J. Koren, Y.-J. Zhang, Y.-f. Xu, U. K. Jinwal, M. J. Birnbaum, B. Monks, M. Sun, J. Q. Cheng, C. Patterson, et al. Akt and CHIP coregulate tau degradation through coordinated interactions PNAS, March 4, 2008; 105(9): 3622 - 3627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Cao, H.-J. Song, T. Gangi, A. Kelkar, I. Antani, D. Garza, and M. Konsolaki Identification of Novel Genes That Modify Phenotypes Induced by Alzheimer's {beta}-Amyloid Overexpression in Drosophila Genetics, March 1, 2008; 178(3): 1457 - 1471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Solano, M. J. Casarejos, J. Menendez-Cuervo, J. A. Rodriguez-Navarro, J. Garcia de Yebenes, and M. A. Mena Glial Dysfunction in Parkin Null Mice: Effects of Aging J. Neurosci., January 16, 2008; 28(3): 598 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-M. Mocanu, A. Nissen, K. Eckermann, I. Khlistunova, J. Biernat, D. Drexler, O. Petrova, K. Schonig, H. Bujard, E. Mandelkow, et al. The Potential for -Structure in the Repeat Domain of Tau Protein Determines Aggregation, Synaptic Decay, Neuronal Loss, and Coassembly with Endogenous Tau in Inducible Mouse Models of Tauopathy J. Neurosci., January 16, 2008; 28(3): 737 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Elliott, P. Tsvetkov, and I. Ginzburg BAG-1 Associates with Hsc70{middle dot}Tau Complex and Regulates the Proteasomal Degradation of Tau Protein J. Biol. Chem., December 21, 2007; 282(51): 37276 - 37284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. N. Rosser, E. Washburn, P. J. Muchowski, C. Patterson, and D. M. Cyr Chaperone Functions of the E3 Ubiquitin Ligase CHIP J. Biol. Chem., August 3, 2007; 282(31): 22267 - 22277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. P. Wang, J. Biernat, M. Pickhardt, E. Mandelkow, and E.-M. Mandelkow Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model PNAS, June 12, 2007; 104(24): 10252 - 10257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Adachi, M. Waza, K. Tokui, M. Katsuno, M. Minamiyama, F. Tanaka, M. Doyu, and G. Sobue CHIP Overexpression Reduces Mutant Androgen Receptor Protein and Ameliorates Phenotypes of the Spinal and Bulbar Muscular Atrophy Transgenic Mouse Model J. Neurosci., May 9, 2007; 27(19): 5115 - 5126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Kumar, R. K. Ambasta, V. Veereshwarayya, K. M. Rosen, K. S. Kosik, H. Band, R. Mestril, C. Patterson, and H. W. Querfurth CHIP and HSPs interact with {beta}-APP in a proteasome-dependent manner and influence A{beta} metabolism Hum. Mol. Genet., April 1, 2007; 16(7): 848 - 864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Blard, S. Feuillette, J. Bou, B. Chaumette, T. Frebourg, D. Campion, and M. Lecourtois Cytoskeleton proteins are modulators of mutant tau-induced neurodegeneration in Drosophila Hum. Mol. Genet., March 1, 2007; 16(5): 555 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Al-Ramahi, Y. C. Lam, H.-K. Chen, B. de Gouyon, M. Zhang, A. M. Perez, J. Branco, M. de Haro, C. Patterson, H. Y. Zoghbi, et al. CHIP Protects from the Neurotoxicity of Expanded and Wild-type Ataxin-1 and Promotes Their Ubiquitination and Degradation J. Biol. Chem., September 8, 2006; 281(36): 26714 - 26724. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Dickey, M. Yue, W.-L. Lin, D. W. Dickson, J. H. Dunmore, W. C. Lee, C. Zehr, G. West, S. Cao, A. M. K. Clark, et al. Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species. J. Neurosci., June 28, 2006; 26(26): 6985 - 6996. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. C. Kraemer, J. K. Burgess, J. H. Chen, J. H. Thomas, and G. D. Schellenberg Molecular pathways that influence human tau-induced pathology in Caenorhabditis elegans Hum. Mol. Genet., May 1, 2006; 15(9): 1483 - 1496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Dorval and P. E. Fraser Small Ubiquitin-like Modifier (SUMO) Modification of Natively Unfolded Proteins Tau and {alpha}-Synuclein J. Biol. Chem., April 14, 2006; 281(15): 9919 - 9924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Berger, B. Ravikumar, F. M. Menzies, L. G. Oroz, B. R. Underwood, M. N. Pangalos, I. Schmitt, U. Wullner, B. O. Evert, C. J. O'Kane, et al. Rapamycin alleviates toxicity of different aggregate-prone proteins Hum. Mol. Genet., February 1, 2006; 15(3): 433 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Grelle, S. Kostka, A. Otto, B. Kersten, K. F. Genser, E.-C. Muller, S. Walter, A. Boddrich, U. Stelzl, C. Hanig, et al. Identification of VCP/p97, Carboxyl Terminus of Hsp70-interacting Protein (CHIP), and Amphiphysin II Interaction Partners Using Membrane-based Human Proteome Arrays Mol. Cell. Proteomics, February 1, 2006; 5(2): 234 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. Miller, R. F. Nelson, C. M. Gouvion, A. Williams, E. Rodriguez-Lebron, S. Q. Harper, B. L. Davidson, M. R. Rebagliati, and H. L. Paulson CHIP Suppresses Polyglutamine Aggregation and Toxicity In Vitro and In Vivo J. Neurosci., October 5, 2005; 25(40): 9152 - 9161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Esser, M. Scheffner, and J. Hohfeld The Chaperone-associated Ubiquitin Ligase CHIP Is Able to Target p53 for Proteasomal Degradation J. Biol. Chem., July 22, 2005; 280(29): 27443 - 27448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shin, J. Klucken, C. Patterson, B. T. Hyman, and P. J. McLean The Co-chaperone Carboxyl Terminus of Hsp70-interacting Protein (CHIP) Mediates {alpha}-Synuclein Degradation Decisions between Proteasomal and Lysosomal Pathways J. Biol. Chem., June 24, 2005; 280(25): 23727 - 23734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Dedmon, J. Christodoulou, M. R. Wilson, and C. M. Dobson Heat Shock Protein 70 Inhibits {alpha}-Synuclein Fibril Formation via Preferential Binding to Prefibrillar Species J. Biol. Chem., April 15, 2005; 280(15): 14733 - 14740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. R. Jana, P. Dikshit, A. Goswami, S. Kotliarova, S. Murata, K. Tanaka, and N. Nukina Co-chaperone CHIP Associates with Expanded Polyglutamine Protein and Promotes Their Degradation by Proteasomes J. Biol. Chem., March 25, 2005; 280(12): 11635 - 11640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. Auluck, M. C. Meulener, and N. M. Bonini Mechanisms of Suppression of {alpha}-Synuclein Neurotoxicity by Geldanamycin in Drosophila J. Biol. Chem., January 28, 2005; 280(4): 2873 - 2878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Lo Bianco, B. L. Schneider, M. Bauer, A. Sajadi, A. Brice, T. Iwatsubo, and P. Aebischer Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an {alpha}-synuclein rat model of Parkinson's disease PNAS, December 14, 2004; 101(50): 17510 - 17515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. E. Riley, Y. Xu, H. Y. Zoghbi, and H. T. Orr The Effects of the Polyglutamine Repeat Protein Ataxin-1 on the UbL-UBA Protein A1Up J. Biol. Chem., October 1, 2004; 279(40): 42290 - 42301. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-I Sze, M. Su, S. Pugazhenthi, P. Jambal, L.-J. Hsu, J. Heath, L. Schultz, and N.-S. Chang Down-regulation of WW Domain-containing Oxidoreductase Induces Tau Phosphorylation in Vitro: A POTENTIAL ROLE IN ALZHEIMER'S DISEASE J. Biol. Chem., July 16, 2004; 279(29): 30498 - 30506. [Abstract] [Full Text] [PDF]
|
|